170 related articles for article (PubMed ID: 3596737)
1. Porphyrinogenic effect of hexachlorobenzene and 2,3,7,8-tetrachlorodibenzo-para-dioxin: is an inhibitor involved in uroporphyrinogen decarboxylase inactivation?
Cantoni L; Graziani A; Rizzardini M; Saletti MC
IARC Sci Publ; 1986; (77):449-56. PubMed ID: 3596737
[TBL] [Abstract][Full Text] [Related]
2. Continued depression of hepatic uroporphyrinogen decarboxylase activity caused by hexachlorobenzene or 2,3,7,8-tetrachlorodibenzo-p-dioxin despite regeneration after partial hepatectomy.
Smith AG; Francis JE; Greig JB
Biochem Pharmacol; 1985 May; 34(10):1817-20. PubMed ID: 4004897
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical studies of the uroporphyrinogen decarboxylase defect caused by hexachlorobenzene.
Elder GH; Urquhart AJ
IARC Sci Publ; 1986; (77):441-8. PubMed ID: 3596736
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene.
Elder GH; Sheppard DM
Biochem Biophys Res Commun; 1982 Nov; 109(1):113-20. PubMed ID: 7159416
[No Abstract] [Full Text] [Related]
5. Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria.
Adjarov DG; Elder GH
IARC Sci Publ; 1986; (77):467-9. PubMed ID: 3596742
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic studies of the inhibition of hepatic uroporphyrinogen decarboxylase in C57BL/10 mice by iron-hexachlorobenzene synergism.
Smith AG; Francis JE; Kay SJ; Greig JB; Stewart FP
Biochem J; 1986 Sep; 238(3):871-8. PubMed ID: 3800966
[TBL] [Abstract][Full Text] [Related]
7. Genetic, iron status and sex factors of porphyria induced by hexachlorobenzene.
Smith AG; Stewart FP; Francis JE
IARC Sci Publ; 1986; (77):433-9. PubMed ID: 3596735
[TBL] [Abstract][Full Text] [Related]
8. Hepatic toxicity and uroporphyrinogen decarboxylase activity following a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin to mice.
Smith AG; Francis JE; Kay SJ; Greig JB
Biochem Pharmacol; 1981 Oct; 30(20):2825-30. PubMed ID: 7317077
[No Abstract] [Full Text] [Related]
9. Effects of polychlorinated biphenyl compounds, 2,3,7,8-tetrachlorodibenzo-p-dioxin, phenobarbital and iron on hepatic uroporphyrinogen decarboxylase. Implications for the pathogenesis of porphyria.
De Verneuil H; Sassa S; Kappas A
Biochem J; 1983 Jul; 214(1):145-51. PubMed ID: 6412692
[TBL] [Abstract][Full Text] [Related]
10. Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
Smith AG; Francis JE
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):377-84. PubMed ID: 7394329
[TBL] [Abstract][Full Text] [Related]
11. The role of contaminants in hexachlorobenzene toxicity.
Sweeney GD; Basford D; Krestynski F
IARC Sci Publ; 1986; (77):363-70. PubMed ID: 3036697
[TBL] [Abstract][Full Text] [Related]
12. Rat-liver porphyrinogen carboxy-lyase inhibition as a function of the degree of hexachlorobenzene-induced porphyria.
Billi SC; Wainstok de Calmanovici R; San Martín de Viale LC
IARC Sci Publ; 1986; (77):487-91. PubMed ID: 3596746
[TBL] [Abstract][Full Text] [Related]
13. Chemically-induced formation of an inhibitor of hepatic uroporphyrinogen decarboxylase in inbred mice with iron overload.
Smith AG; Francis JE
Biochem J; 1987 Aug; 246(1):221-6. PubMed ID: 3675556
[TBL] [Abstract][Full Text] [Related]
14. Alterations of uroporphyrinogen decarboxylase by chlorinated organics.
Elder GH; Roberts AG; Urquhart AJ
Ann N Y Acad Sci; 1987; 514():141-7. PubMed ID: 3442378
[No Abstract] [Full Text] [Related]
15. Experimental hepatic porphyria caused by hexachlorobenzene: mechanism of the metabolic block.
De Matteis F
IARC Sci Publ; 1986; (77):427-31. PubMed ID: 3596734
[No Abstract] [Full Text] [Related]
16. The involvement of iron and lipid peroxidation in the pathogenesis of HCB induced porphyria.
Alleman MA; Koster JF; Wilson JH; Edixhoven-Bosdijk A; Slee RG; Kroos MJ; von Eijk HG
Biochem Pharmacol; 1985 Jan; 34(2):161-6. PubMed ID: 3966921
[TBL] [Abstract][Full Text] [Related]
17. Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria.
Smith AG; Francis JE; Dinsdale D; Manson MM; Cabral JR
Carcinogenesis; 1985 Apr; 6(4):631-6. PubMed ID: 3986965
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibitory effect on porphyrinogen carboxylyase of liver extracts from TCDD treated mice.
Cantoni L; dal Fiume D; Rizzardini M; Ruggieri R
Toxicol Lett; 1984 Feb; 20(2):211-7. PubMed ID: 6695412
[TBL] [Abstract][Full Text] [Related]
19. Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Sweeny GD; Jones KG; Cole FM; Basford D; Krestynski F
Science; 1979 Apr; 204(4390):332-5. PubMed ID: 432648
[TBL] [Abstract][Full Text] [Related]
20. Liver porphyrinogen carboxylase in hexachlorobenzene porphyric rats. Studies with intermediate porphyrinogens of series III and with uroporphyrinogen I.
Ríos de Molina MC; Wainstok de Calmanovici R; San Martín de Viale LC
Int J Biochem; 1987; 19(4):365-72. PubMed ID: 3595984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
